Dosage · AOD-9604

    AOD-9604 Dosage in the Literature

    Dosages reported in peer-reviewed clinical research on AOD-9604. This page summarizes what the published literature contains — it is not a prescription, protocol, or recommendation. Only a qualified physician can determine whether AOD-9604 is appropriate for you and at what dose.

    The Dosing Evidence Engine

    We don’t tell clinicians what to prescribe. We show them what the evidence says.

    Every dosing range, treatment duration, and protocol displayed is sourced from published literature and accompanied by the underlying study references and evidence grading.

    Published Study Citations

    Detailed dosage extractions are being curated for AOD-9604. In the meantime, review the full evidence profile and citations on the AOD-9604 clinical reference page.

    Educational summary of peer-reviewed citations. TruthTides does not publish dosing protocols. Of the 35 compounds covered on TruthTides, only three — semaglutide, tirzepatide, and tesamorelin — carry FDA approval; the remainder are compounded, investigational, or off-label. Always consult a qualified physician before starting any peptide therapy.